Pevonedistat targets malignant cells in myeloproliferative neoplasms in vitro and in vivo via NFκB pathway inhibition

Autor: Kong, Tim *, Laranjeira, Angelo B.A. *, Collins, Taylor B. *, De Togni, Elisa S., Wong, Abigail J., Fulbright, Mary C., Ruzinova, Marianna, Celik, Hamza, Challen, Grant A., Fisher, Daniel A.C., Oh, Stephen T. *
Zdroj: In Blood Advances 25 January 2022 6(2):611-623
Databáze: ScienceDirect